Pulmonary embolism as a cause of death in patients who died with cancer
- PMID: 16443419
- DOI: 10.1016/j.amjmed.2005.02.028
Pulmonary embolism as a cause of death in patients who died with cancer
Abstract
Little is known about the frequency of death from pulmonary embolism in patients who die with cancer. We investigated this on the basis of data from death certificates, as listed by the United States Bureau of the Census in the period 1980-1998. Among patients with cancer who died over the 19-year period of study, pulmonary embolism was the listed cause of death in 0.21% (95% confidence interval, [CI] 0.21-0.22%). The frequency of death from pulmonary embolism in patients who died with cancer decreased from 0.39% in 1980 to 0.15% in 1998. Adjustment of the data for the frailty of the diagnosis of fatal pulmonary embolism based on death certificates indicated a likely range of 0.60% to 1.05% for the frequency of death from pulmonary embolism among patients who died with cancer in the period 1980-1998. In conclusion, with modern diagnostic, prophylactic, and therapeutic methods, death from pulmonary embolism in patients who died with cancer was 1% or less.
Similar articles
-
Pulmonary embolism as a cause of death in adults who died with heart failure.Am J Cardiol. 2006 Oct 15;98(8):1073-5. doi: 10.1016/j.amjcard.2006.05.030. Epub 2006 Aug 28. Am J Cardiol. 2006. PMID: 17027574
-
Fatal pulmonary embolism and stroke.Am J Cardiol. 2006 Jun 15;97(12):1776-7. doi: 10.1016/j.amjcard.2006.01.042. Epub 2006 Apr 27. Am J Cardiol. 2006. PMID: 16765133
-
The clinical course of pulmonary embolism.N Engl J Med. 1992 May 7;326(19):1240-5. doi: 10.1056/NEJM199205073261902. N Engl J Med. 1992. PMID: 1560799
-
Long-term incidence of death due to thromboembolic disease among patients with unprovoked pulmonary embolism.Curr Opin Pulm Med. 2009 Sep;15(5):418-24. doi: 10.1097/MCP.0b013e32832d044a. Curr Opin Pulm Med. 2009. PMID: 19458530 Review.
-
Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review.J Clin Psychiatry. 1995 Jan;56(1):21-5. J Clin Psychiatry. 1995. PMID: 7836335 Review.
Cited by
-
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.Oncologist. 2017 May;22(5):601-608. doi: 10.1634/theoncologist.2016-0246. Epub 2017 Apr 19. Oncologist. 2017. PMID: 28424324 Free PMC article.
-
Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen.Curr Oncol. 2020 Dec 22;28(1):128-137. doi: 10.3390/curroncol28010016. Curr Oncol. 2020. PMID: 33704181 Free PMC article.
-
Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer.J Korean Med Sci. 2019 Jun 2;34(21):e160. doi: 10.3346/jkms.2019.34.e160. J Korean Med Sci. 2019. PMID: 31144482 Free PMC article.
-
Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial.J Thromb Thrombolysis. 2021 Apr;51(3):720-724. doi: 10.1007/s11239-020-02317-y. Epub 2020 Oct 20. J Thromb Thrombolysis. 2021. PMID: 33079379 Clinical Trial.
-
In-hospital prognosis of malignancy-related pulmonary embolism: an analysis of the national inpatient sample 2016-2018.J Thromb Thrombolysis. 2022 Nov;54(4):630-638. doi: 10.1007/s11239-022-02684-8. Epub 2022 Jul 25. J Thromb Thrombolysis. 2022. PMID: 35876942
MeSH terms
LinkOut - more resources
Full Text Sources
Medical